1.
|
Phase: Phase IV Type: Supportive care Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: A1501038, NCT00143312
|
|
2.
|
Phase: Phase III Type: Supportive care Status: Closed Age: 12 and over Sponsor: Pharmaceutical / Industry Protocol IDs: EORTC-19961, PFIZER-150-307-000, NCT00003031
|
|
3.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 12 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: NCI-98-C-0063, PFIZER-150-603
|
|
4.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 12 and over Sponsor: NCI Protocol IDs: NCI-99-C-0094B, NCI-99-C-0094
|
|
5.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: A1501029, NCT00150345
|
|
6.
|
Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 2 to 12 Sponsor: NCI, NHLBI Protocol IDs: 416, BMTCTN-0101, UF-G-074-2003, FHCRC-1808.00, CDR0000349374, U01 HL069294, NCT00075803
|
|
7.
|
Phase: Phase II Type: Supportive care Status: Completed Age: 2 and over Sponsor: NCI Protocol IDs: NCI-03-C-0111, NCT00059878
|
|
8.
|
Phase: Phase II Type: Supportive care Status: Completed Age: 2 to 11 Sponsor: NCI Protocol IDs: NCI-03-C-0218, NCT00066599
|
|
9.
|
Phase: Phase I Type: Supportive care Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MCV-CCHR-9603-2H, PFIZER-95CK39-0673, NCI-G97-1325
|
|
10.
|
Phase: Phase I Type: Supportive care Status: Completed Age: 2 to 12 Sponsor: NCI Protocol IDs: NCI-00-C-0150
|
|
11.
|
Phase: No phase specified Type: Supportive care Status: Closed Age: 12 and over Sponsor: NCI Protocol IDs: UCLA-0307071, NCT00079222
|
|
12.
|
Phase: No phase specified Type: Supportive care, Treatment Status: Completed Age: 2 and over Sponsor: NHLBI Protocol IDs: 139, NCT00023530
|